JD

Joshua Disbrow

Chairman & Chief Executive Officer

Aytu BioScience

Denver, Colorado


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Aytu BioScience
Industry
pharmaceuticals
Employees
120.0
Seniority
C suite
Annual Revenue
65000000.0

Technologies

Outlook GoDaddy Hosting Microsoft Office 365 Google Analytics Mobile Friendly Apache Gravity Forms Google Tag Manager reCAPTCHA Vimeo WordPress.org Nginx Google Font API Remote IoT Micro

Keywords

pharmaceuticals pediatrics adhd consumer health biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing prescription drugs patient support program patient access rxconnect treatment for adhd innovative therapeutics healthcare solutions fluoride deficiency allergy treatments central nervous system stimulants patient wellness pediatric healthcare novel therapeutics clinical development healthcare partnerships corporate governance strategic licensing market access strategies pharmaceutical development healthcare delivery clinical trials therapeutic innovations patient compliance healthcare equity diversity in hiring regulatory affairs quality assurance environmental sustainability social responsibility patient-centered care healthcare technology drug commercialization pediatric prescriptions chronic conditions treatment access to medications pharmaceutical acquisition business development life sciences healthcare stakeholders patient education programs community engagement long-term medication management innovations in therapeutics prescribing information allergic conditions treatment fluoride supplements healthcare investment active ingredient development medical hospital & health care health wellness & fitness b2b

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans